Pressure Biosciences Inc Quick Ratio (PBIO) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Pressure Biosciences Inc   (PBIO)

Pressure Biosciences Inc 's Quick Ratio

PBIO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2024, Quick Ratio deteriorated to 0 a new company low.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Quick Ratio than Pressure Biosciences Inc in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 4568 to 4652.

Explain Quick Ratio?
How much Cash & cash equivalents PBIO´s has?
What are PBIO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBIO Quick Ratio (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2
Y / Y Current Liabilities Change 64.18 % 29.55 % -6.84 % -25.93 % -10.78 %
Y / Y Cash & cash equivalent Change -42.93 % -98.65 % 2002.95 % -97.7 % -79.46 %
Quick Ratio MRQ 0 0 0 0 0
PBIO's Total Ranking # 4652 # 4568 # 4026 # 5535 #
Seq. Current Liabilities Change -2.23 % 32.74 % 40.37 % -9.87 % -22.85 %
Seq. Cash & cash equivalent Change 342.64 % -96.04 % 1433.57 % -78.78 % -89.55 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 25
Healthcare Sector # 1010
Overall Market # 4652


Quick Ratio Statistics
High Average Low
0.15 0.02 0
(Dec 31 2014)   (Mar 31 2024)




Financial Statements
Pressure Biosciences Inc 's Current Liabilities $ 44 Millions Visit PBIO's Balance sheet
Pressure Biosciences Inc 's Cash & cash equivalent $ 0 Millions Visit PBIO's Balance sheet
Source of PBIO's Sales Visit PBIO's Sales by Geography


Cumulative Pressure Biosciences Inc 's Quick Ratio

PBIO's Quick Ratio for the trailling 12 Months

PBIO Quick Ratio

 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 12.66 % -2.93 % -5.5 % -0.54 % 15.49 %
Y / Y Cash & cash equivalent TTM Growth -79.14 % -80.72 % -26.21 % -54.74 % -51.87 %
Quick Ratio TTM 0 0 0 0 0
Total Ranking TTM # 3721 # 3159 # 3456 # 3723 #
Seq. Current Liabilities TTM Growth 13.25 % 8.58 % -2.04 % -6.48 % -2.42 %
Seq. Cash & cash equivalent TTM Growth -9.34 % -67.26 % 28.34 % -45.23 % -16.23 %

Quick ratio ranking by company, industry and sector >> Back to PBIO Financial Strength Comparisons >> Go to Compare PBIO Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the Q2 2024 to $43.58 millions, cumulative Quick Ratio